fda bpc-157 unapproved new drug panel votes to place popular peptide on compounding list bpc-157 unapproved drug fda warning

Reduced Inflammation: This peptide has potent anti-inflammatory properties, which help minimize swelling and inflammation in injured or damaged areas

Stability data suggests lyophilized BPC-157 tolerates up to 72 cumulative hours at 2025C before crossing the 15% potency loss threshold that most researchers consider unacceptable

Many people lack enough Vitamin B12 in their diet, which can sap their energy and leave their nerves feeling off

The principal amino acid detected in metabolism studies is proline, consistent with BPC-157's sequence containing five proline residues that comprise one-third of its structure